Quadruple induction immunosuppression after liver transplantation with IL-2 receptor antibody (BT 563) is equally effective and better tolerated than ATG induction therapy

Transplant Proc. 1993 Feb;25(1 Pt 1):587-9.

Authors

B Neuhaus¹, H Keck, W O Bechstein, G Blumhardt, J M Langrehr, M Wiens, H P Lemmens, R Lohmann, H Schlag, U Thalmann, et al.

Affiliation

¹ Department of Surgery, University Clinic Rudolf Virchow, Free University Berlin, Germany.

PMID: 8438426

No abstract available

Publication types

Clinical Trial
Comparative Study

MeSH terms

Antibodies, Monoclonal / therapeutic use*
Antilymphocyte Serum / therapeutic use*
Azathioprine / therapeutic use
Biopsy
Cyclosporine / therapeutic use
Humans
Immunosuppression Therapy / methods*
Liver Transplantation / immunology*
Liver Transplantation / pathology
Prednisolone / therapeutic use
Receptors, Interleukin-2 / immunology*
Retrospective Studies
Transplantation, Homologous

Substances

Antibodies, Monoclonal
Antilymphocyte Serum
Receptors, Interleukin-2
Cyclosporine
Prednisolone
inolimomab
Azathioprine